Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

TXG

10x Genomics Inc

Dec 20 • 04:00PM ET

14.04

Dollar change +0.43
Percentage change 3.16	%

Healthcare • Health Information Services • USA • NASD

Peers: ILMN NTRA PACB FLGT CDNA MYGN GH EXAS QDEL TWST

| Held by: ARKK VTI VB ARKG VXF VBK IBB SCHA IWP VHT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.53	Insider Own	17.60%	Shs Outstand	106.98M	Perf Week	-1.16%
Market Cap	1.75B	Forward P/E	-	EPS next Y	-1.26	Insider Trans	-0.12%	Shs Float	99.75M	Perf Month	5.41%
Income	-182.55M	PEG	-	EPS next Q	-0.31	Inst Own	78.78%	Short Float	6.92%	Perf Quarter	-36.79%
Sales	629.74M	P/S	2.78	EPS this Y	34.54%	Inst Trans	-0.95%	Short Ratio	3.30	Perf Half Y	-29.38%
Book/sh	5.97	P/B	2.35	EPS next Y	11.86%	ROA	-19.36%	Short Interest	6.90M	Perf Year	-74.26%
Cash/sh	3.19	P/C	4.40	EPS next 5Y	-	ROE	-24.87%	52W Range	12.95 - 57.90	Perf YTD	-74.91%
Dividend Est.	-	P/FCF	67.33	EPS past 5Y	-13.04%	ROI	-22.84%	52W High	-75.75%	Beta	1.83
Dividend TTM	-	Quick Ratio	4.12	Sales past 5Y	35.76%	Gross Margin	65.73%	52W Low	8.42%	ATR (14)	0.98
Dividend Ex-Date	-	Current Ratio	4.90	EPS Y/Y TTM	20.22%	Oper. Margin	-28.30%	RSI (14)	42.35	Volatility	7.91% 6.23%
Employees	1259	Debt/Eq	0.12	Sales Y/Y TTM	6.56%	Profit Margin	-28.99%	Recom	2.30	Target Price	20.20
Option/Short	Yes / Yes	LT Debt/Eq	0.11	EPS Q/Q	62.51%	Payout	-	Rel Volume	0.97	Prev Close	13.61
Sales Surprise	-3.34%	EPS Surprise	8.70%	Sales Q/Q	-1.30%	Earnings	Oct 29 AMC	Avg Volume	2.09M	Price	14.04
SMA20	-7.54%	SMA50	-8.25%	SMA200	-37.03%	Trades		Volume	2,024,544	Change	3.16%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-03-24	Initiated	Leerink Partners	Outperform	$35
Jul-22-24	Upgrade	Jefferies	Hold → Buy	$24
Jul-18-24	Downgrade	JP Morgan	Overweight → Neutral	$40 → $20
Jul-10-24	Downgrade	Deutsche Bank	Buy → Hold	$55 → $25
Jun-27-24	Downgrade	Wolfe Research	Outperform → Peer Perform
Jun-25-24	Downgrade	Guggenheim	Buy → Neutral
Jun-03-24	Resumed	Jefferies	Hold	$24
May-01-24	Downgrade	TD Cowen	Buy → Hold	$57 → $32
Dec-14-23	Initiated	Guggenheim	Buy	$60
Dec-13-23	Initiated	Wolfe Research	Outperform	$55
Dec-12-23	Upgrade	BofA Securities	Underperform → Neutral	$36 → $54
Jul-05-23	Resumed	JP Morgan	Overweight	$65
May-10-23	Initiated	Barclays	Overweight	$65
Mar-31-23	Initiated	Stephens	Overweight	$65
Feb-02-23	Initiated	UBS	Neutral	$50
Dec-14-22	Initiated	Deutsche Bank	Buy	$50
Aug-18-22	Downgrade	Goldman	Neutral → Sell	$55 → $35
Jul-25-22	Initiated	Canaccord Genuity	Buy	$55
Jul-15-22	Downgrade	William Blair	Outperform → Mkt Perform
Jul-15-22	Downgrade	BofA Securities	Neutral → Underperform	$35

Show Previous Ratings

Nov-20-24 03:29PM	If RFK Jr. Cuts Science Funding, These Instrument Makers May Suffer (Barrons.com)
Nov-19-24 07:11PM	10x Genomics, Inc. (TXG): Among the Best Genomics Stocks to Buy Right Now (Insider Monkey)
Nov-07-24 04:05PM	10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference (PR Newswire)
Oct-31-24 08:00AM	TechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery Initiative (PR Newswire)
Oct-30-24 07:36AM	Q3 2024 10X Genomics Inc Earnings Call (Thomson Reuters StreetEvents)
03:14AM	Loading…
03:14AM	10x Genomics Inc (TXG) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
Oct-29-24 07:00PM	10x Genomics (TXG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:20PM	10x Genomics (TXG) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:15PM	10x Genomics: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	10x Genomics Reports Third Quarter 2024 Financial Results (PR Newswire)
Oct-23-24 12:00PM	10x Genomics (TXG) Upgraded to Strong Buy: Here's Why (Zacks)
Oct-22-24 10:01AM	10x Genomics (TXG) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Oct-15-24 04:05PM	10x Genomics Delivers 'Single Cell for a Single Cent' with New Chromium Launches (PR Newswire)
Oct-10-24 04:14PM	These Stocks Moved the Most Today: Tesla, Super Micro, AMD, and More (Barrons.com) -24.70%
01:26PM	These Stocks Are Moving the Most Today: Tesla, Delta, Super Micro, First Solar, AMD, 10x Genomics, PayPal, and More (Barrons.com)
07:36AM	Loading…
07:36AM	Gene Sequencing Tech Provider 10x Genomics' Q3 Sales Fall Short On Expectations, But CEO Sees Opportunity Ahead (Benzinga)
Oct-09-24 05:57PM	10x Genomics Inc (TXG) Q2 2024 Earnings Call Highlights: Navigating Growth Amidst Macroeconomic ... (GuruFocus.com)
04:05PM	10x Genomics Announces Preliminary Select Third Quarter 2024 Results (PR Newswire)
Oct-04-24 05:05PM	Vanguard Group's Strategic Acquisition in 10x Genomics Inc (GuruFocus.com)
Oct-01-24 04:05PM	10x Genomics Announces Mega-Scale Single Cell Analysis for One Cent Per Cell at Human Cell Atlas General Meeting (PR Newswire) -5.62% -5.54%
Sep-10-24 09:00AM	Lausanne Researchers Combine 10x Genomics' Chromium and Xenium for Novel Insights into Resistance and Potential Therapeutics for Brain Cancer (PR Newswire)
Sep-03-24 04:05PM	10x Genomics Unveils Chromium Xo: A Low-Cost Instrument to Expand Access to High-Performance Single Cell Research (PR Newswire)
Aug-22-24 04:05PM	10x Genomics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference (PR Newswire) +5.57%
Aug-12-24 03:01PM	Catherine Wood's Strategic Acquisition in 10x Genomics Inc. (GuruFocus.com)
Aug-08-24 06:00PM	10x Genomics (TXG) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) +7.83%
05:45PM	10x Genomics (TXG) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:45PM	10x Genomics: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	10x Genomics Announces Senior Leadership Changes (PR Newswire)
04:04PM	10x Genomics Reports Second Quarter 2024 Financial Results (PR Newswire)
Aug-07-24 09:15AM	Unlocking Q2 Potential of 10x Genomics (TXG): Exploring Wall Street Estimates for Key Metrics (Zacks)
04:00PM	Loading…
Aug-05-24 04:00PM	10x Genomics Technology Supports TenK10K Project Led by Garvan Institute of Medical Research to Help Transform the Treatment of Complex Diseases (PR Newswire)
Aug-01-24 10:01AM	10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Jul-21-24 11:49PM	10x Genomics, Inc. (TXG): Hedge Funds Think This Stock Will Skyrocket (Insider Monkey)
Jul-17-24 09:55AM	Does 10x Genomics (TXG) Have the Potential to Rally 85.65% as Wall Street Analysts Expect? (Zacks)
Jul-12-24 09:15AM	10x Genomics (TXG) Surges 8.2%: Is This an Indication of Further Gains? (Zacks)
08:00AM	10x Genomics to Report Second Quarter 2024 Financial Results on August 8, 2024 (PR Newswire)
Jul-10-24 02:10PM	Illumina Deal Sends 10x Genomics Stock Tumbling (Barrons.com) -13.92%
Jun-27-24 09:00AM	New Insights Into Cleft Palate Unlocked With 10x Genomics' Single Cell and Spatial Technologies (PR Newswire)
Jun-25-24 08:14AM	Does 10x Genomics (TXG) Have a Strong Growth Opportunity Ahead? (Insider Monkey)
Jun-20-24 09:00AM	10x Genomics Begins Commercial Shipments of Xenium Prime 5K Pan-Tissue and Pathways Panel (PR Newswire)
Jun-07-24 01:01PM	Baillie Gifford Reduces Stake in 10x Genomics Inc. (GuruFocus.com)
May-29-24 04:05PM	10x Genomics Launches 5,000-Plex Gene Panel for Xenium (PR Newswire)
May-10-24 07:01AM	Shhh! 3 Secret Nanotech Stocks Flying Below Wall Street's Radar (InvestorPlace)
May-07-24 02:45PM	Bruker's NanoString Secures Patent Case Win in Germany (MT Newswires)
May-06-24 01:04PM	Cathie Wood's Latest Buys: 3 Stocks the ARK Invest CEO Can't Get Enough Of (InvestorPlace)
09:08AM	International Markets and 10x Genomics (TXG): A Deep Dive for Investors (Zacks)
May-02-24 04:05PM	10x Genomics to Present at the BofA Securities 2024 Healthcare Conference (PR Newswire)
06:04AM	3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire (InvestorPlace)
May-01-24 12:59PM	UBS Adjusts 10x Genomics Price Target to $30 From $52, Maintains Neutral Rating (MT Newswires) -8.06%
11:33AM	10x Genomics, Inc. (NASDAQ:TXG) Q1 2024 Earnings Call Transcript (Insider Monkey)
11:05AM	Q1 2024 10X Genomics Inc Earnings Call (Thomson Reuters StreetEvents)
03:27AM	10x Genomics Inc (TXG) (Q1 2024) Earnings Call Transcript Highlights: Diverse Revenue Streams ... (GuruFocus.com)
01:01AM	Curio Bioscience Reports Clarifying Decision From European Unified Patent Court (UPC) (Business Wire)
Apr-30-24 08:57PM	TXG Stock Earnings: 10x Genomics Meets EPS, Misses Revenue for Q1 2024 (InvestorPlace)
06:30PM	10x Genomics (TXG) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:43PM	10x Genomics Inc (TXG) Q1 2024 Earnings: Misses Analyst Expectations Amidst New Product Launches (GuruFocus.com)
04:38PM	10x Genomics: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	10x Genomics Reports First Quarter 2024 Financial Results (PR Newswire)
Apr-29-24 11:01AM	Canaccord Genuity Adjusts Price Target on 10x Genomics to $50 From $65, Maintains Buy Rating (MT Newswires)
Apr-25-24 11:28AM	11 Oversold MidCap Stocks To Buy Now (Insider Monkey)
Apr-24-24 09:35AM	Down -23.92% in 4 Weeks, Here's Why 10x Genomics (TXG) Looks Ripe for a Turnaround (Zacks)
Apr-23-24 10:01AM	10x Genomics (TXG) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Apr-22-24 12:00PM	10x Genomics (TXG) Upgraded to Buy: Here's What You Should Know (Zacks)
Apr-18-24 06:46AM	Bruker to acquire Nanostring for $393M (MedTech Dive)
Apr-10-24 04:05PM	10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024 (PR Newswire) -5.51%
Mar-26-24 09:00AM	10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay (PR Newswire)
Mar-21-24 04:05PM	10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel (PR Newswire)
Mar-13-24 04:05PM	10x Genomics Begins Commercial Shipments of Chromium GEM-X Products (PR Newswire)
08:17AM	11 Oversold Healthcare Stocks To Buy Right Now (Insider Monkey)
Mar-01-24 02:00PM	Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too? (InvestorPlace)
Feb-27-24 11:55AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Feb-20-24 04:05PM	10x Genomics to Present at the 44th Annual TD Cowen Health Care Conference (PR Newswire)
Feb-16-24 10:21AM	10x Genomics, Inc. (NASDAQ:TXG) Q4 2023 Earnings Call Transcript (Insider Monkey)
08:14AM	Q4 2023 10X Genomics Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-15-24 06:00PM	Here's What Key Metrics Tell Us About 10x Genomics (TXG) Q4 Earnings (Zacks)
05:20PM	10x Genomics (TXG) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:40PM	10x Genomics Inc (TXG) Reports Solid Revenue Growth Amid Rising Operating Expenses in FY 2023 (GuruFocus.com)
04:17PM	10x Genomics: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024 (PR Newswire)
Feb-08-24 10:00AM	10x Genomics (TXG) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release (Zacks) +5.26%
Feb-07-24 04:05PM	10x Genomics Expands Leadership in Single Cell Analysis with Launch of GEM-X Technology (PR Newswire)
Feb-05-24 04:05PM	10x Genomics to Showcase New Cutting-Edge Technologies and Highlight Innovation Roadmap at 2024 AGBT General Meeting (PR Newswire) +6.41%
11:18AM	Nanostring files for bankruptcy protection, explores possible sale (MedTech Dive)
Jan-30-24 01:03PM	Baillie Gifford Reduces Stake in 10x Genomics Inc (GuruFocus.com)
Jan-24-24 04:05PM	10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024 (PR Newswire)
Jan-08-24 09:00AM	10x Genomics Announces Preliminary Fourth Quarter and Full Year 2023 Results (PR Newswire)
Dec-21-23 04:05PM	10x Genomics to Present at the 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-20-23 04:05PM	10x Genomics Launches Xenium Catalyst Network (PR Newswire)
Dec-19-23 09:00AM	Integrative Study Conducted by 10x Genomics Combines Single Cell, Spatial and In Situ Analyses to Investigate Tumor Invasiveness (PR Newswire) +5.82%
Dec-13-23 04:26PM	High Sensitivity and Specificity of the Xenium Platform from 10x Genomics Outperforms NanoString's CosMx and Vizgen's Merscope in Benchmarking Preprint (PR Newswire) +5.26% +7.75%
Dec-10-23 11:59AM	12 Best Genomics Stocks To Buy Now (Insider Monkey)
Dec-07-23 09:00AM	10x Genomics and NIH CARD to Create Comprehensive Single Cell Atlas of the Human Brain (PR Newswire)
Nov-23-23 11:05AM	Insider Sell Alert: Chief Commercial Officer James Wilbur Sells Shares of 10x Genomics Inc (GuruFocus.com)
Nov-19-23 09:08AM	Harvard University Stocks List: Top 12 Picks (Insider Monkey)
Nov-17-23 05:22PM	10x Genomics Wins Another Patent Infringement Case Against NanoString Technologies (PR Newswire) +5.58%
Nov-09-23 01:12AM	Here's Why You Should Invest in 10x Genomics (TXG) (Insider Monkey)
Nov-06-23 04:05PM	OWKIN Integrates 10x Genomics Spatial Omics and Single-Cell Technologies to the MOSAIC Study (PR Newswire)
Nov-03-23 11:09AM	10x Genomics, Inc. (NASDAQ:TXG) Q3 2023 Earnings Call Transcript (Insider Monkey) +8.73%
09:14AM	Q3 2023 10X Genomics Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-02-23 07:43PM	10x Genomics Inc (TXG) Reports 17% Revenue Increase in Q3 2023 (GuruFocus.com) +6.44%

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company's products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Saxonov Serge	Chief Executive Officer	Nov 22 '24	Sale	13.69	6,693	91,612	872,574	Nov 25 04:53 PM
Hindson Benjamin J.	See Remarks	Nov 22 '24	Sale	13.69	5,807	79,485	339,897	Nov 25 04:52 PM
Hindson Benjamin J.	Officer	Nov 22 '24	Proposed Sale	13.32	5,734	76,377		Nov 22 04:56 PM
Saxonov Serge	Officer	Nov 22 '24	Proposed Sale	13.32	6,608	88,019		Nov 22 04:38 PM
Saxonov Serge	Chief Executive Officer	Aug 22 '24	Sale	22.53	6,749	152,053	882,467	Aug 26 05:05 PM
Hindson Benjamin J.	See Remarks	Aug 22 '24	Sale	22.53	4,351	98,027	345,704	Aug 26 05:04 PM
McAnear Justin J.	Former Chief Financial Officer	Aug 22 '24	Sale	22.53	2,961	66,710	143,242	Aug 26 05:03 PM
Saxonov Serge	Officer	Aug 22 '24	Proposed Sale	23.01	6,749	155,294		Aug 22 08:45 PM
McAnear Justin J.	Officer	Aug 22 '24	Proposed Sale	23.01	2,961	68,133		Aug 22 08:42 PM
Hindson Benjamin J.	Officer	Aug 22 '24	Proposed Sale	23.01	4,351	100,117		Aug 22 08:39 PM
McAnear Justin J.	Chief Financial Officer	May 22 '24	Sale	24.30	2,936	71,355	146,203	May 23 07:54 PM
Saxonov Serge	Chief Executive Officer	May 22 '24	Sale	24.30	4,877	118,529	889,641	May 23 07:53 PM
Hindson Benjamin J.	See Remarks	May 22 '24	Sale	24.30	4,087	99,329	350,055	May 23 07:52 PM
Saxonov Serge	Chief Executive Officer	Mar 04 '24	Sale	44.00	4,660	205,021	842,900	Mar 06 04:12 PM
Saxonov Serge	Chief Executive Officer	Feb 22 '24	Sale	46.34	2,821	130,737	847,560	Feb 26 04:13 PM
Hindson Benjamin J.	See Remarks	Feb 22 '24	Sale	46.34	2,613	121,098	283,059	Feb 26 04:12 PM
McAnear Justin J.	Chief Financial Officer	Feb 22 '24	Sale	46.34	1,865	86,432	95,240	Feb 26 04:12 PM
Saxonov Serge	Chief Executive Officer	Feb 15 '24	Sale	48.87	5,000	244,332	850,381	Feb 20 04:20 PM
Saxonov Serge	Chief Executive Officer	Feb 09 '24	Sale	49.53	1,000	49,530	855,381	Feb 13 04:56 PM
Saxonov Serge	Chief Executive Officer	Jan 16 '24	Sale	45.24	4,000	180,956	856,381	Jan 18 04:49 PM
Hindson Benjamin J.	See Remarks	Dec 28 '23	Option Exercise	11.48	8,334	95,674	285,672	Dec 29 04:19 PM
Saxonov Serge	Chief Executive Officer	Dec 27 '23	Option Exercise	1.20	14,935	17,922	860,381	Dec 29 04:17 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TXG

10x Genomics Inc

Upgrade your FINVIZ experience